Pfizer accused of vaccine testing fraud

The so-called “clinical trials” (https://bit.ly/3NhbGdS) that Pfizer
conducted on its messenger RNA (mRNA) Wuhan coronavirus
(Covid-19) “vaccine” appear to have been completely fraudulent,
which means the company could one day be held liable for all
associated injuries and deaths.
Documents released in November 2021 by the U.S. Food and Drug
Administration (FDA) as part of a court-mandated information
dump reveal that enrollment at one particular trial site happened
at warp speed, just in time to meet the safety deadline for the FDA’s
VRBPAC meeting on Dec. 10, 2020.
This meeting is where the FDA discussed granting Emergency Use
Authorization (EUA) for the Pfizer-BioNTech injection in people
16 years of age and older. 
“The allegedly suspicious-looking clinical trial data surrounds ‘the
biggest recruiter by far,’ site 1231 (site 4444 was assigned site id
1231) in Argentina,” reported Undercover DC.
“Adding to the confusion, in five short days before the safety
deadline (including a Sunday, 9/27/20), the trial recruited 1,275
of the 4,501 people using site number 4444. In just three weeks,
the site recruited 4,501 patients – 10% of the entire trial
at one site.”
“Overall, Pfizer rapidly recruited roughly 44,000 people for their
trial, which took place at 152 locations worldwide and was
overseen by numerous investigators, including Dr. Fernando
Polack, who led the Argentinian study at Hospital Militar Central.”
Prof. Norman Fenton from Queen Mary University
(https://bit.ly/3sBauKa) of London added in his own two-part Substack
series that what was supposedly pulled off in Argentina on behalf of
Pfizer is “basically impossible.”
“[I]f this really happened,” he wrote, “it would be a wonder of the
world, and they should publish the process with pride and win 27
different prizes for it.”
“They claim to have enrolled seven days a week for three weeks with
zero gaps. Each patient requires a 250-page case report form,” Fenton
added. “The lead investigator seems to have been Fernando Polack.”
“If indeed, the best way to get things done is to give them to busy
people, then this was a great choice because, from the look of
things, Fernando is one busy fellah and connected up the wazoo
to boot. He also works with Vanderbilt, the FDA, and the Infant
Foundation, funded by the Gates Foundation and the NIH.”
In the disclosure forms associated with a New England Journal
of Medicine (NEJM) paper on Pfizer’s injection, Polack’s conflicts
of interest are revealed. They show personal fees he accepted from
not only Pfizer but also Janssen (Johnson & Johnson), Regeneron
(monoclonal antibodies), Merck & Co. and Novavax.